Understanding what makes a good versus a bad vaccine

European Journal of Immunology

Volumn 35, Issue 9, 2005, Pages 2528-2531

  Harari, Alexandre ^a   Pantaleo, Giuseppe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Animal models; HIV; Immune responses; Vaccination

Indexed keywords

ADENOVIRUS VACCINE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; POXVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VIVO STUDY; INJECTION SITE REACTION; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; SKIN MANIFESTATION; STEM CELL MOBILIZATION; T LYMPHOCYTE; VACCINATION; VIRUS IMMUNITY; VIRUS INFECTION;

AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; MICE; VACCINATION;

EID: 26044475165     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535335     Document Type: Article

References (14)

1. McMichael, A. J. and Hanke, T., HIV vaccines 1983-2003. Nat. Med. 2003. 7: 874-880.
2. Letvin, N. L., Progress toward an HIV vaccine. Annu. Rev. Med. 2005. 56: 213-223.
3. Shiver, J. W. and Emini, E. A., Recent advances in the development of HN-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 2004. 55: 355-372.
4. Hirsch, V. M., Fuerst, T. R., Suffer, G., Carroll, M. W., Yang, L. C., Goldstein, S., Piatak, M. et al., Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 1996. 6: 3741-3752.
5. Shiver, J. W., Fu, T. M., Chen, L., Casimiro, D. R., Davies, M. E., Evans, R. K., Zhang, Z. Q. et al., Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002. 6869: 331-335.
6. + cytotoxic T lymphocyte responses in seronegative volunteers. J. Infect. Dis. 1999. 2: 290-298.
7. Casimiro, D. R., Tang, A., Chen, L., Fu, T. M., Evans, R. K., Davies, M. E., Freed, D. C. et al. Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 2003. 13: 7663-7668.
8. Amara, R. R., Villinger, F., Altman, J. D., Lydy, S. L., O'Neil, S. P., Staprans, S. I., Montefiori, D. C. et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001. 5514: 69-74.
9. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 1998. 4: 397-402.
10. Hanke, T., Blanchard, T. J., Schneider, J., Hannan, C. M., Becker, M., Gilbert, S. C., Hill, A. V. et al. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine 1998. 5: 439-445.
11. Casimiro, D. R., Chen, L., Fu, T. M., Evans, R. K., Caulfield, M. J., Davies, M. E., Tang, A. et al. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 2003. 11: 6305-6313.
12. + T cell responses. Eur. J. Immunol. 2005. 35: 2532-2540.
13. Barouch, D. H., Pau, M. G., Custers, J. H., Koudstaal, W., Kostense, S., Havenga, M. J., Truitt, D. M. et al., Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J. Immunol. 2004. 10: 6290-6297.
14. Hanke, T., Samuel, R. V., Blanchard, T. J., Neumann, V. C., Allen, T. M., Boyson, J. E., Sharpe, S. A. et al. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J. Virol. 1999. 9: 7524-7532.